SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-289588
Filing Date
2023-12-06
Accepted
2023-12-06 08:31:56
Documents
12
Period of Report
2023-12-06

Document Format Files

Seq Description Document Type Size
1 6-K d620025d6k.htm 6-K 22766
2 EX-4.1 d620025dex41.htm EX-4.1 88663
3 EX-4.2 d620025dex42.htm EX-4.2 96880
4 EX-4.3 d620025dex43.htm EX-4.3 97507
5 EX-4.4 d620025dex44.htm EX-4.4 18798
6 EX-5.1 d620025dex51.htm EX-5.1 45450
7 EX-5.2 d620025dex52.htm EX-5.2 11565
8 EX-10.1 d620025dex101.htm EX-10.1 207781
9 EX-99.1 d620025dex991.htm EX-99.1 10041
10 GRAPHIC g620025g1205122830462.jpg GRAPHIC 2746
11 GRAPHIC g620025snap1.jpg GRAPHIC 9320
12 GRAPHIC g620025snap2.jpg GRAPHIC 4178
  Complete submission text file 0001193125-23-289588.txt   623418
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 231468492
SIC: 2834 Pharmaceutical Preparations